Evidence map›Paper›PMID 40341159›Full record

ArticleScientific reports2025

Assessment of the biofilm formation capacities of Staphylococcus aureus strains Newman and Newman D2C in vitro and in vivo.

Ben Wieland, Gubesh Gunaratnam, Linda Pätzold, Noran Abdel Wadood, Georges Pierre Schmartz, Swarnali Kundu, Nikolay Krasimirov Kirilov, Ina Krüger, Mohamed Ibrahem Elhawy, Jacqueline Rehner and 7 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ben WielandInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Gubesh GunaratnamInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Linda PätzoldInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Noran Abdel WadoodInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Georges Pierre SchmartzClinical Bioinformatics, Saarland University, 66123, Saarbrücken, Germany.
Swarnali KunduInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Nikolay Krasimirov KirilovInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Ina KrügerInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Mohamed Ibrahem ElhawyInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Jacqueline RehnerInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Hannah HeintzExperimental Physics, Center for Biophysics, Saarland University, 66123, Saarbrücken, Germany.
Frank SchmitzInstitute of Anatomy and Cell Biology, Saarland University, 66421, Homburg, Germany.
Daniela YildizPreclinical Center for Molecular Signaling, Molecular Pharmacology, Saarland University, 66421, Homburg, Germany.
Gabriela Krasteva-ChristInstitute of Anatomy and Cell Biology, Saarland University, 66421, Homburg, Germany.
Sören Leif BeckerInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany.
Karin JacobsExperimental Physics, Center for Biophysics, Saarland University, 66123, Saarbrücken, Germany.
Markus BischoffInstitute of Medical Microbiology and Hygiene, Saarland University, 66421, Homburg, Germany. markus.bischoff@uks.eu.

Funding

Deutsche Forschungsgemeinschaft 519828155Deutsche Forschungsgemeinschaft DFG INST 256/508-1Deutsche Forschungsgemeinschaft SFB10127/B2Marie Skłodowska-Curie COFUND-Action of the European Union 101081463Saarland University and the Helmholtz Institute for Pharmaceutical Research Saarland UdS-HIPS-Tandem
6 · The paper itself

Abstract

Staphylococcus aureus is a major cause of implant-associated infections (IAIs). The ability of this Gram-positive bacterium to cause IAIs is closely related to its capacity to attach to and to form biofilms on the implant material. Biofilm formation of S. aureus on artificial surfaces is usually mimicked in the laboratory by simple microplate-based in vitro assays and often involves type culture collection preserved laboratory strains such as SA113 (ATCC 35556), Newman (NCTC 8178), and Newman D2C (NCTC 10833, ATCC 25904). The latter two strains are phylogenetically closely related and often inadvertently indicated as strain "Newman" in publications, albeit of the fact that strain Newman D2C harbors among others mutations in the global regulatory loci agr and sae, which strongly impact the phenotypic behavior of this strain. Wondering how the genetic differences between strains Newman and Newman D2C alter the biofilm formation capacities of these two strains in vitro and in vivo, we tested here the adhesion behavior and biofilm formation capacities of both strains on different kinds of artificial surfaces (tissue culture-treated bottoms of 96-well polystyrene microplates and polyurethane-based peripheral venous catheter [PVC] tubing). Additionally, we determined their ability to cause infection in a foreign body-related murine infection model. Our studies revealed that the Newman and Newman D2C derivatives kept at Saarland University, Germany, differ significantly in their abilities to attach to microplate well bottoms and PVC tubing, and to form biofilms in various static and dynamic in vitro assays. However, when the biofilm formation capacities of both strains were determined in an in vivo infection model, rather comparable bacterial loads were observed. These findings suggest that biofilm formation capacities of S. aureus strains may differ substantially in vitro and in vivo. Additionally, researchers working with strains Newman and Newman D2C should be aware that both strains differ substantially in their phenotypic behavior, and that both strains should be indicated correctly to allow for a better comparison of data obtained with these strains in different laboratories.

Indexed as

BiofilmsStaphylococcal InfectionsStaphylococcus aureusAnimalsBacterial AdhesionFemaleMiceAdhesionBiofilm formationForeign body-related murine infection modelGrowth kineticsNCTC 10833NCTC 8178Staphylococcus aureusStrain NewmanStrain Newman D2C

Identifiers

PMID40341159
PMCPMC12062259

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.